View in EDS PDF Full Text

Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.

Saved in:
Bibliographic Details
Title: Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.
Authors: Cornforth TV; Enara Bio Ltd., Oxford, United Kingdom., Moyo N; Enara Bio Ltd., Oxford, United Kingdom., Cole S; Enara Bio Ltd., Oxford, United Kingdom., Lam EPS; Enara Bio Ltd., Oxford, United Kingdom., Lobry T; Enara Bio Ltd., Oxford, United Kingdom., Wolchinsky R; Enara Bio Ltd., Oxford, United Kingdom., Lloyd A; Enara Bio Ltd., Oxford, United Kingdom., Ward K; Enara Bio Ltd., Oxford, United Kingdom., Denham EM; Enara Bio Ltd., Oxford, United Kingdom., Masi G; Enara Bio Ltd., Oxford, United Kingdom., Qing Yun PT; Enara Bio Ltd., Oxford, United Kingdom., Moore C; Enara Bio Ltd., Oxford, United Kingdom., Dhaouadi S; Enara Bio Ltd., Oxford, United Kingdom., Besra GS; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom., Veerapen N; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom., Illing PT; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Vivian JP; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Raynes JM; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Le Nours J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Purcell AW; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Kundu S; Enara Bio Ltd., Oxford, United Kingdom., Silk JD; Enara Bio Ltd., Oxford, United Kingdom., Williams L; Enara Bio Ltd., Oxford, United Kingdom., Papa S; Enara Bio Ltd., Oxford, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Institute of Infection and Immunity, Cardiff University, School of Medicine, Cardiff, United Kingdom., Howie D; Enara Bio Ltd., Oxford, United Kingdom., Dukes J; Enara Bio Ltd., Oxford, United Kingdom.
Source: Frontiers in oncology [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1419528. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39445059
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cornforth+TV%22">Cornforth TV</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moyo+N%22">Moyo N</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cole+S%22">Cole S</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lam+EPS%22">Lam EPS</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lobry+T%22">Lobry T</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wolchinsky+R%22">Wolchinsky R</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lloyd+A%22">Lloyd A</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ward+K%22">Ward K</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Denham+EM%22">Denham EM</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Masi+G%22">Masi G</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Qing+Yun+PT%22">Qing Yun PT</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moore+C%22">Moore C</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dhaouadi+S%22">Dhaouadi S</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Besra+GS%22">Besra GS</searchLink>; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Veerapen+N%22">Veerapen N</searchLink>; Institute of Microbiology and Infection, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Illing+PT%22">Illing PT</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Vivian+JP%22">Vivian JP</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Raynes+JM%22">Raynes JM</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Le+Nours+J%22">Le Nours J</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Purcell+AW%22">Purcell AW</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kundu+S%22">Kundu S</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Silk+JD%22">Silk JD</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Williams+L%22">Williams L</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Papa+S%22">Papa S</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.; School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rossjohn+J%22">Rossjohn J</searchLink>; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Institute of Infection and Immunity, Cardiff University, School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Howie+D%22">Howie D</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dukes+J%22">Dukes J</searchLink>; Enara Bio Ltd., Oxford, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 Oct 03; Vol. 14, pp. 1419528. <i>Date of Electronic Publication: </i>2024 Oct 03 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39445059
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2024.1419528
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1419528
    Titles:
      – TitleFull: Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cornforth TV
      – PersonEntity:
          Name:
            NameFull: Moyo N
      – PersonEntity:
          Name:
            NameFull: Cole S
      – PersonEntity:
          Name:
            NameFull: Lam EPS
      – PersonEntity:
          Name:
            NameFull: Lobry T
      – PersonEntity:
          Name:
            NameFull: Wolchinsky R
      – PersonEntity:
          Name:
            NameFull: Lloyd A
      – PersonEntity:
          Name:
            NameFull: Ward K
      – PersonEntity:
          Name:
            NameFull: Denham EM
      – PersonEntity:
          Name:
            NameFull: Masi G
      – PersonEntity:
          Name:
            NameFull: Qing Yun PT
      – PersonEntity:
          Name:
            NameFull: Moore C
      – PersonEntity:
          Name:
            NameFull: Dhaouadi S
      – PersonEntity:
          Name:
            NameFull: Besra GS
      – PersonEntity:
          Name:
            NameFull: Veerapen N
      – PersonEntity:
          Name:
            NameFull: Illing PT
      – PersonEntity:
          Name:
            NameFull: Vivian JP
      – PersonEntity:
          Name:
            NameFull: Raynes JM
      – PersonEntity:
          Name:
            NameFull: Le Nours J
      – PersonEntity:
          Name:
            NameFull: Purcell AW
      – PersonEntity:
          Name:
            NameFull: Kundu S
      – PersonEntity:
          Name:
            NameFull: Silk JD
      – PersonEntity:
          Name:
            NameFull: Williams L
      – PersonEntity:
          Name:
            NameFull: Papa S
      – PersonEntity:
          Name:
            NameFull: Rossjohn J
      – PersonEntity:
          Name:
            NameFull: Howie D
      – PersonEntity:
          Name:
            NameFull: Dukes J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 10
              Text: 2024 Oct 03
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1